About Touchlight genetics ltd
Touchlight Genetics Ltd: Revolutionizing Gene Therapy with its Revolutionary DNA Technology
Touchlight Genetics Ltd is a UK-based biotechnology company that specializes in the development of revolutionary DNA technology for gene therapy. The company was founded in 2008 by Dr. Jonny Ohlson, a renowned scientist and entrepreneur, who envisioned a world where genetic diseases could be cured using safe and effective gene therapies.
Touchlight Genetics' proprietary dbDNA™ technology is based on the production of high-quality linear DNA molecules that are free from bacterial contaminants and can be used as templates for the production of therapeutic proteins. This innovative approach to gene therapy has several advantages over traditional methods, including increased safety, efficacy, and scalability.
The company's mission is to develop breakthrough treatments for genetic diseases such as cancer, rare genetic disorders, and infectious diseases. Touchlight Genetics' cutting-edge technology has already attracted significant interest from pharmaceutical companies looking to develop new therapies based on its unique platform.
In addition to its core research activities, Touchlight Genetics also offers a range of services related to DNA synthesis and analysis. These include custom oligonucleotide synthesis, plasmid preparation, sequencing services, and bioinformatics analysis.
One of the key strengths of Touchlight Genetics is its team of highly skilled scientists with expertise in molecular biology, genetics, biochemistry, and biotechnology. The company's research facilities are equipped with state-of-the-art equipment for DNA synthesis and analysis.
Touchlight Genetics has received several awards for its innovative approach to gene therapy. In 2019 it was awarded the prestigious Queen's Award for Enterprise in Innovation in recognition of its groundbreaking work on dbDNA™ technology.
The future looks bright for Touchlight Genetics as it continues to push the boundaries of what is possible in gene therapy. With an expanding portfolio of patents covering various aspects of dbDNA™ technology and collaborations with leading pharmaceutical companies around the world; this UK-based biotech firm is poised to become a major player in the field of gene therapy.
In conclusion, Touchlight Genetics Ltd is a biotechnology company that is revolutionizing gene therapy with its innovative dbDNA™ technology. The company's mission is to develop safe and effective treatments for genetic diseases using cutting-edge molecular biology techniques. With its team of highly skilled scientists and state-of-the-art research facilities, Touchlight Genetics is well-positioned to make significant contributions to the field of gene therapy in the years ahead.